Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on November 16, 2010. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Request for Information - TRICARE Pharmacy Program 4 (TPharm4)

Closed
RFI-TPharm4Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 446110
Federal
Specialty Pharmacy Fulfillment of Lenalidomide (Revlimid)The contract involves the specialty pharmacy fulfillment and delivery of Lenalidomide (Revlimid), a medication used primarily in the treatment of certain cancers and blood disorders, to patients of the Department of Veterans Affairs (VA). The contractor is responsible for dispensing either branded or therapeutically equivalent versions of Lenalidomide in varying strengths. This service must comply with Risk Evaluation and Mitigation Strategies (REMS) protocols, ensuring safe and effective use of the medication. Essential contract activities include verifying prescriptions, conducting patient outreach to support medication adherence and understanding, securely packaging the medication, and ensuring delivery is confirmed by obtaining signatures upon receipt. This subcontract is issued by the 252-NETWORK Contract Office 12 under the Department of Veterans Affairs and aligns with NAICS code 446110, which typically covers pharmacies and drug stores. While specific performance location details and points of contact are not provided, the contract underscores the importance of compliance with federal safety standards and thorough patient management. The seamless coordination of prescription verification, patient communication, packaging, and secure delivery highlights the contractor’s critical role in supporting VA patients’ access to this specialized pharmaceutical therapy.
252-NETWORK Contract Office 12 (36C252)

POSTED

9 months ago

DEADLINE

N/A

General Info

NAICS

446110 - Pharmacies and Drug Stores

Place of Performance

CO

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts2 people available
OfficeAURORA, CO, 80011, USA
Office AddressAURORA, CO, 80011, USA
Contacts
William H. CoffenberryContracting Officer
Dwight BonhamContract Specialist

Full Description

Show more
Request for Information for a Department of Defense (DoD) Acquisition and Management of Services in Support of the TRICARE Pharmacy Program (TPharm) 1.0 SUBJECT The TRICARE Management Activity (TMA) is conducting market research to determine current capabilities of commercial pharmacy benefit management services that provide Home Delivery pharmacy (including specialty pharmacy) services, retail pharmacy networks, claims adjudication, and fiscal intermediary functions. Responses are due to this RFI by 4:00 PM on December 17, 2010. See section 5.0 for further information. 2.0 DISCLAIMER This Request for Information (RFI) is issued solely for information and planning purposes only and does not constitute a solicitation. Neither unsolicited proposals nor any other kinds of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. All information received in response to this RFI that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future RFP will not be entertained. 3.0 DESCRIPTION TRICARE is the US Department of Defense (DoD) health care plan using military health care as the main delivery system. This system is augmented by a civilian network of providers and facilities serving uniformed service members, their families, retired military, and their families worldwide. TMA is the DoD organization responsible for managing the TRICARE health care benefit. This includes managing the integration of state of the art technologies to enhance patient safety, efficiency, and cost effectiveness. For DoD beneficiaries, the TRICARE Pharmacy Program (TPharm) provides the Home Delivery pharmacy (including specialty pharmacy) services, provides a retail pharmacy network, provides claims adjudication, and serves as a fiscal intermediary on behalf of DoD to pay for all authorized pharmaceuticals and supplies dispensed for beneficiaries at retail pharmacies. TMA is seeking information from industry that will assist in the future TRICARE pharmacy benefit management service contract that will support the MHS. The intent is to maintain and if possible enhance capabilities within the Military Health System (MHS). 4.0 REQUIREMENTS This section enumerates potential functional requirements for the future TPharm pharmacy benefit management service contract. Can industry support the following TPharm contract configurations? a) Configuration 1) Claims processing, historical claims data storage (warehouse), drug utilization reviews, and mail fulfillment as separate contracted functions. 2) Claims processing, historical claims data storage (warehouse), drug utilization reviews, and mail fulfillment as combined contracted functions. The discussion of capability should include the pro's and cons of each. b) Prime Vendor 1) Using the DoD national prime vendor contract for mail fulfillment? 2) Using a contractor's commercial prime vendor contract for mail fulfillment? The discussion of capability should include how the government can ensure procurement costs are equal to or lower than federal ceiling prices or other government contracted prices. c) Specialty Pharmacy 1) The establishment of a national specialty pharmacy network. The discussion of capability should include the optimal number of participating specialty pharmacies needed to provide the maximum coverage at the least cost. 2) The establishment of a mechanism to allow contracted specialty pharmacies to purchase drugs through a central distribution point. The discussion of capability should include the best mechanism to ensure the government receives federal discounts for specialty drugs. 3) The provision of clinical services to assist patients receiving specialty medications is an important aspect of care. What should those services include and how should those services be monitored for effectiveness? What criteria should be used to determine if a pharmacy is acceptable for inclusion in the specialty pharmacy network? d) Network Access Standards 1) The establishment of variable network access standards? The discussion of capability should include whether a smaller network would significantly reduce government costs without adversely impacting beneficiary satisfaction. The discussion of capability should include the optimal number of network pharmacies that balances costs with access based on current commercial practices. e) Data Separation 1) The separation of DoD pharmacy data from other commercial data when designing a retail claims processing and mail fulfillment contract? The discussion of capability should include whether it is practical and cost effective to do so. f) Medication Therapy Management (MTM) 1) Discuss current retail pharmacy applications of MTM services in place today. What services are provided, how are these services reimbursed and measured for effectiveness? g) Data Warehouse 1) DoD pharmacy data is maintained in a data warehouse separate from claims adjudication. Discuss the pros and cons of combining claims processing and data warehouse capabilities on a single platform. The purpose of this RFI is to gather information about those requirements enumerated above. To the extent simplifying assumptions are needed, respondents are encouraged to make and document such assumptions in their responses. This RFI seeks information about approaches that could meet the functional requirements. In doing so, the Government seeks to understand the tradeoffs among risks, costs (initial and ongoing) and alternative technical architectures that incorporate increasing degrees of sharing. The Government welcomes alternative concepts for solutions that meet these requirements including an overview of new technologies or approaches to providing the requested or similar functionality. The Government encourages creativity and outside the box thinking in responses to this RFI. 5.0 CONTACT INFORMATION Following is the Point of Contact (POC) for this RFI: William H. Coffenberry Contracting Officer TRICARE Management Activity 16401 E. Centretech Parkway Aurora, CO 80011 (303) 676-3764 William.Coffenberry@tma.osd.mil Please submit responses via e-mail in Microsoft Office 2003 (at a minimum) format by 4:00 PM on December 17, 2010, to Mr. William H. Coffenberry. You may also submit supplemental hardcopy materials such as brochures, etc to the address above.

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 811210
New
Federal
Zeiss Meditec Ophthalmology Equipment Maintenance
Solicitation # HT940627QE003
Solicitation HT940627QE003 is a Request for Quote issued by the Defense Health Agency, Healthcare Contracting Division-Southeast, for a firm-fixed-price contract to provide full-service maintenance for Zeiss MediTec ophthalmology equipment at the Naval Medical Center Camp Lejeune in North Carolina. The scope of work includes regularly scheduled preventative maintenance, timely onsite repairs, and software updates for specific devices, including the CIRRUS 5000, IOLMASTER 700, HFA3 B60, and ATLAS 900. All services must be performed according to manufacturer recommendations and applicable FDA regulations. The contract consists of a base period from December 1, 2026, to November 30, 2027, with four subsequent option periods extending the potential performance through November 30, 2031. This procurement is a total small business set-aside under NAICS code 811210. Award will be made based on the Lowest Priced Technically Acceptable (LPTA) basis, where technical capability is evaluated independently of price. Offerors must submit two separate volumes: Volume I for technical capability, which must describe the functional approach and methodology without identifying company names or logos, and Volume II for comprehensive pricing. Quotes are due by 8:00 am Eastern Time on October 29, 2026. Payment and invoicing will be processed electronically through the Wide Area WorkFlow system.
Electronic and Precision Equipment Repair and Maintenance

POSTED

2 days ago

DEADLINE

in 8 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies from a preferred Technology Readiness Level of 5 or higher to a final state of TRL 7 or 8, culminating in mandatory U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning standard FAR and DFARS regulations do not apply unless expressly referenced. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals are due by November 6, 2026, and must be submitted in three distinct volumes covering technical approach, management capability, and administrative cost and price. To be eligible, offerors must be registered in the System for Award Management and meet specific criteria, such as being a nontraditional defense contractor or a small business.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

2 days ago

DEADLINE

in 16 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS